• No results found

Improving the Properties of Ni-ZrO2 Composite Coatings by Sol-Enhanced Electroplating

N/A
N/A
Protected

Academic year: 2019

Share "Improving the Properties of Ni-ZrO2 Composite Coatings by Sol-Enhanced Electroplating"

Copied!
9
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Table 1. Process for Preparation of ZrO2 sol
Table 2. Bath composition and electroplating parameters for Ni-ZrO2 composite coatings
Figure 1.  Surface morphologies of Ni–ZrO2 composite coatings: (1) ZrO2 powder:(a) Ni–ZrO2 (2.5 g/L), (b) Ni–ZrO2 (10 g/L), (c) Ni–ZrO2 (20 g/L); (2) ZrO2 sol-enhanced:(d) Ni–ZrO2 (5 ml/L), (e) Ni–ZrO2 (15 ml/L), and (f) Ni–ZrO2 (30 ml/L)
Figure 2.  XRD patterns of sol enhanced Ni-ZrO2 composite coatings with different concentration of ZrO2 sol addition
+4

References

Related documents

• Competitive Benchmark Price Analysis: Observed prices in California in Summer 2000 were greater than benchmark competitive price levels; these differences are not fully

Antibiotics drug usage pattern in pediatric patients enrolled in the study. Table 13: Antibiotics drug usage pattern in

allows for only structural break but not nonlinear adjustment, rejects the unit root null. hypothesis in seven cases only, i.e., in cases of the Czech Republic,

It can be seen that the medication emerges from the injection ports off- center and predisposed to the artery wall, compared to the symmetric emergence of medication from the

The comparison of the electron density contours of HOMO of cyclic and open structures shows noticeable difference of electron distribution of both forms, where

In-situ Monitoring of Internal Temperature, Flow Rate and Pressure in the High-temperature Proton Exchange Membrane Fuel Cell Stack using Flexible Integrated Micro Sensor*.

PL emission spectra of PbS nanostructures in the visible region and for infrared region (as an inset) synthesized at various synthesis temperatures but at constant molar

In STK4-deficient mice, treatment with an IRAK1/4 inhibitor after DEN administration reduced serum IL-6 levels and liver tumor numbers to levels similar to those observed in the